Compounded Tirzepatide

Units vs Milligrams: How to Read a Tirzepatide Syringe

The vial talks in milligrams. The syringe talks in units. Here is the translation - and why you should never do the math alone.

6 min read·Sources: FDA prescribing information, peer-reviewed trials and NIH literature·Updated August 2026·Educational content, not medical advice
The short answer

Insulin-syringe units measure volume, not medicine: 100 units equal 1 mL. How many units correspond to 2.5 mg of tirzepatide depends entirely on the concentration your pharmacy dispensed, which is printed on your vial's label. Your dispensed instructions state your exact draw; if anything on the label seems inconsistent, confirm with the pharmacy or your clinician before injecting.

See your price Takes about 10 minutes · a clinician can decline · full refund if not prescribed
Morning light on a kitchen counter with a glass of water

Units measure volume, not dose

An insulin syringe is marked in units because it was designed for insulin. One hundred units is one milliliter of liquid – that is all a unit means. The amount of medicine in that milliliter depends on how concentrated the vial is, and concentration varies between compounding pharmacies.

Why there is no universal answer

Ask the internet how many units make 2.5 mg and you will get confident, contradictory answers – because people are quoting different concentrations. At 2.5 mg/mL, 2.5 mg is 100 units. At 5 mg/mL, it is 50 units. At 10 mg/mL, it is 25 units. Same dose, three different draws. This is why a number copied from a forum can be dangerously wrong for your vial.

Where your real answer lives

Two places, and they should agree: the concentration printed on your vial label, and the draw-to line written in your dispensed instructions. Compounding pharmacies state the draw in units precisely so you never have to convert anything yourself.

Tirzepatide activates both the GIP and the GLP-1 receptor – two gut-hormone pathways, not one.

FDA prescribing information, tirzepatide ↗

If the numbers do not line up

Wrong-concentration assumptions are one of the most common self-dosing errors reported with compounded GLP-1 medicines. If your label, instructions, or memory disagree – stop and call the pharmacy or your clinician. A thirty-second call beats a tenfold error. See the 30-second film answers for this medication.

Administering it correctly, in plain terms

Follow the instructions your dispensing pharmacy provides with your specific preparation, because concentration differs between products and that is what determines the volume you draw. Most weekly peptide injections are subcutaneous, into fat rather than muscle, using the abdomen away from the navel, the outer thigh, or the back of the upper arm. Rotating the site each week reduces local irritation. Supplies arrive with the shipment: syringes, alcohol swabs, and a sharps container. Units and milligrams are not interchangeable, and confusing them is the most common self-administration error, which is why units versus milligrams exists as its own article. If anything about your dose, volume, or schedule is unclear, contact the pharmacy or your clinician before injecting rather than estimating.

How tirzepatide works on two receptors at once

Tirzepatide is a single molecule that activates two incretin receptors: GIP and GLP-1. Both are receptors your gut already uses. After a meal, the intestine releases incretin hormones that tell the pancreas to release insulin, slow how fast the stomach empties, and signal fullness to the hypothalamus. Tirzepatide binds those same receptors, so the signal is present at a steadier level than it would be from food alone. The GLP-1 arm is the one most people have heard of. The GIP arm is what distinguishes tirzepatide from semaglutide, which acts on GLP-1 only. According to the FDA prescribing information for tirzepatide products, dual agonism is the mechanism of record. What that difference means for any individual is a clinical question, not a settled one, and a licensed clinician decides whether the medication is appropriate for you at all.

FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

FDA, human drug compounding ↗

What compounded means, and what it does not

A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as SURMOUNT-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.

Why side effects are mostly digestive, and mostly early

Because the receptors tirzepatide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for tirzepatide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.

Curious what your price would be?

No card needed to see it. No insurance accepted or required.

See your price firstTakes about 10 minutes · a clinician can decline · full refund if not prescribed

Frequently asked questions

Is 100 units always 1 mL?

On a standard U-100 insulin syringe, yes – the units scale is a volume scale. What changes between vials is how much medicine each milliliter contains.

Can I use an online units calculator?

Only as a cross-check against the draw printed in your dispensed instructions – never as a replacement for them. The calculator does not know your vial's concentration; your label does.

My new vial looks different from my last one. Same draw?

Not necessarily. Concentration can change between fills. Re-read the label and instructions with every new vial before drawing.

Is compounded tirzepatide the same as Zepbound?

No. Zepbound is an FDA-approved product; a compounded preparation is made by a licensed pharmacy for an individual patient and is not FDA-approved. FDA does not review compounded preparations for safety, effectiveness, or quality before marketing, and a compounded preparation is not a generic or an equivalent.

What is the starting dose of compounded tirzepatide?

Your prescribing clinician sets the starting dose and the titration schedule, and the dispensing pharmacy supplies instructions for your specific concentration. There is no single published starting dose for compounded preparations, and units and milligrams are not interchangeable.

How long can compounded tirzepatide be out of the fridge?

Follow the storage instructions supplied with your preparation, because the permitted excursion window depends on the exact formulation. If a package arrives warm, leaking, cloudy, or damaged, contact the dispensing pharmacy rather than using it.

Unsure about your draw? Ask before you inject

A licensed clinician reviews your history and your pharmacy's instructions. Rx only, refunded in full if you are not prescribed.

Takes about 10 minutes · a clinician can decline · full refund if not prescribed

Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.

Sources

Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.

  1. FDAFDA. Compounding and the FDA: questions and answers
  2. ReferenceISMP. Safe practice guidelines for subcutaneous insulin and volume-based dosing
  3. FDA databaseDrugs@FDA: search approved labeling for tirzepatide
  4. Peer-reviewedSURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity (NEJM 2022)

Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.

More on Compounded Tirzepatide

Same medication, different question.

See your price